Drug Shortage Report for 70% DEXTROSE INJECTION USP
Report ID | 147116 |
Drug Identification Number | 02014874 |
Brand name | 70% DEXTROSE INJECTION USP |
Common or Proper name | 70% Dextrose Injection, USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 70G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 3000mL Bag |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-10-16 |
Actual start date | 2021-10-16 |
Estimated end date | 2021-11-04 |
Actual end date | 2021-11-04 |
Shortage status | Resolved |
Updated date | 2021-11-05 |
Company comments | Baxter is experiencing a supply disruption on 70% Dextrose 3L format (Baxter code JB0297) which will continue until the first week of November. Limited supply of the 2L format (Baxter code 2B0296H) is available. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-10-13 | English | Compare |
v2 | 2021-10-13 | French | Compare |
v3 | 2021-10-17 | English | Compare |
v4 | 2021-11-04 | English | Compare |
v5 | 2021-11-04 | French | Compare |
v6 | 2021-11-05 | English | Compare |
Showing 1 to 6 of 6